Home>>Signaling Pathways>> Endocrinology and Hormones>> Androgen Receptor>>CLP-3094

CLP-3094 Sale

(Synonyms: 2-[2-(4-氯-苯氧基)-乙基硫基]-1H-苯并咪唑) 目录号 : GC62209

CLP-3094, a potent inhibitor targeting the binding function 3 (BF3) site of androgen receptor (AR), inhibits AR transcriptional activity with IC50 of 4 μM, also is a selective, potent GPR142 antagonist.

CLP-3094 Chemical Structure

Cas No.:312749-73-8

规格 价格 库存 购买数量
10mM (in 1mL DMSO)
¥1,287.00
现货
5 mg
¥1,170.00
现货
10 mg
¥2,070.00
现货

电话:400-920-5774 Email: sales@glpbio.cn

Customer Reviews

Based on customer reviews.

Sample solution is provided at 25 µL, 10mM.

产品文档

Quality Control & SDS

View current batch:

产品描述

CLP-3094, a potent inhibitor targeting the binding function 3 (BF3) site of androgen receptor (AR), inhibits AR transcriptional activity with IC50 of 4 μM, also is a selective, potent GPR142 antagonist.

[1] Munuganti RS, et al. J Med Chem. 2013 Feb 14;56(3):1136-48.

Chemical Properties

Cas No. 312749-73-8 SDF
别名 2-[2-(4-氯-苯氧基)-乙基硫基]-1H-苯并咪唑
分子式 C15H13ClN2OS 分子量 304.79
溶解度 DMSO : 100 mg/mL (328.09 mM; Need ultrasonic) 储存条件 Store at -20°C
General tips 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。
Shipping Condition 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。

溶解性数据

制备储备液
1 mg 5 mg 10 mg
1 mM 3.2809 mL 16.4047 mL 32.8095 mL
5 mM 0.6562 mL 3.2809 mL 6.5619 mL
10 mM 0.3281 mL 1.6405 mL 3.2809 mL
  • 摩尔浓度计算器

  • 稀释计算器

  • 分子量计算器

质量
=
浓度
x
体积
x
分子量
 
 
 
*在配置溶液时,请务必参考产品标签上、MSDS / COA(可在Glpbio的产品页面获得)批次特异的分子量使用本工具。

计算

动物体内配方计算器 (澄清溶液)

第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
给药剂量 mg/kg 动物平均体重 g 每只动物给药体积 ul 动物数量
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方)
% DMSO % % Tween 80 % saline
计算重置

Research Update

Discovery and pharmacological effects of a novel GPR142 antagonist

J Recept Signal Transduct Res 2017 Jun;37(3):290-296.PMID:27807998DOI:10.1080/10799893.2016.1247861

GPR142 is a G-protein-coupled receptor (GPCR), whose most potent and efficacious ligand has been reported as being the natural amino acid l-tryptophan. GPR142 is highly expressed in pancreatic β-cells and immune cells, suggesting the receptor may play a role in the pathogenesis and development of diabetes or inflammatory diseases. In a previous report, we developed GPR142 agonists as insulin secretagogues. In this report, we show the discovery of a selective, potent small-molecule GPR142 antagonist, CLP-3094, and its pharmacological characteristics. These data support targeting this receptor for the treatment of chronic inflammatory diseases.